Business Description
Restart Life Sciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA53069P1018
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | -40.23 | |||||
Debt-to-Equity | -0.06 | |||||
Debt-to-EBITDA | -0.14 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3343.83 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 27.8 | |||||
3-Year EPS without NRI Growth Rate | 26.9 | |||||
3-Year FCF Growth Rate | 27.1 | |||||
3-Year Book Growth Rate | -89.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.79 | |||||
9-Day RSI | 52.05 | |||||
14-Day RSI | 52.35 | |||||
6-1 Month Momentum % | -66.67 | |||||
12-1 Month Momentum % | -80 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 78.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -65.3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1528.57 | |||||
Net Margin % | -1496.43 | |||||
FCF Margin % | -175 | |||||
ROA % | -1047.5 | |||||
ROIC % | -839.22 | |||||
ROC (Joel Greenblatt) % | -3890.91 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 35 | |||||
EV-to-EBIT | -3.06 | |||||
EV-to-EBITDA | -3.08 | |||||
EV-to-Revenue | 46.75 | |||||
EV-to-FCF | -23.04 | |||||
Earnings Yield (Greenblatt) % | -32.67 | |||||
FCF Yield % | -3.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Restart Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.028 | ||
EPS (TTM) (C$) | -0.014 | ||
Beta | -2 | ||
Volatility % | 81.56 | ||
14-Day RSI | 52.35 | ||
14-Day ATR (C$) | 0.003992 | ||
20-Day SMA (C$) | 0.0325 | ||
12-1 Month Momentum % | -80 | ||
52-Week Range (C$) | 0.015 - 0.125 | ||
Shares Outstanding (Mil) | 36.02 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Restart Life Sciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Restart Life Sciences Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Restart Life Sciences Corp Frequently Asked Questions
What is Restart Life Sciences Corp(XCNQ:HEAL)'s stock price today?
When is next earnings date of Restart Life Sciences Corp(XCNQ:HEAL)?
Does Restart Life Sciences Corp(XCNQ:HEAL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |